- Home
- PRZO vs APTO Comparison
PRZO vs APTO Comparison
Compare PRZO & APTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRZO
- APTO
- Stock Information
- Founded
- PRZO 2014
- APTO 1986
- Country
- PRZO Israel
- APTO Canada
- Employees
- PRZO N/A
- APTO N/A
- Industry
- PRZO
- APTO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PRZO
- APTO Health Care
- Exchange
- PRZO Nasdaq
- APTO Nasdaq
- Market Cap
- PRZO 7.8M
- APTO 7.2M
- IPO Year
- PRZO 2023
- APTO N/A
- Fundamental
- Price
- PRZO $0.58
- APTO $0.37
- Analyst Decision
- PRZO
- APTO Strong Buy
- Analyst Count
- PRZO 0
- APTO 4
- Target Price
- PRZO N/A
- APTO $9.00
- AVG Volume (30 Days)
- PRZO 140.3K
- APTO 73.2K
- Earning Date
- PRZO 11-25-2024
- APTO 11-08-2024
- Dividend Yield
- PRZO N/A
- APTO N/A
- EPS Growth
- PRZO N/A
- APTO N/A
- EPS
- PRZO N/A
- APTO N/A
- Revenue
- PRZO $558,382.00
- APTO N/A
- Revenue This Year
- PRZO N/A
- APTO N/A
- Revenue Next Year
- PRZO N/A
- APTO N/A
- P/E Ratio
- PRZO N/A
- APTO N/A
- Revenue Growth
- PRZO N/A
- APTO N/A
- 52 Week Low
- PRZO $0.49
- APTO $0.33
- 52 Week High
- PRZO $1.87
- APTO $2.91
- Technical
- Relative Strength Index (RSI)
- PRZO 45.39
- APTO 49.17
- Support Level
- PRZO $0.56
- APTO $0.37
- Resistance Level
- PRZO $0.63
- APTO $0.41
- Average True Range (ATR)
- PRZO 0.04
- APTO 0.02
- MACD
- PRZO -0.00
- APTO 0.00
- Stochastic Oscillator
- PRZO 47.43
- APTO 42.00
About PRZO ParaZero Technologies Ltd.
ParaZero Technologies Ltd is an aerospace company that is focused on drone safety systems and engaged in the business of designing, developing, and providing autonomous parachute safety systems for commercial drones, also known as unmanned aerial systems. The ParaZero SafeAir system of the comapany applies real-time data analytics to identify and mitigate flight risks autonomously and increase safety for bystanders while protecting the loss of expensive drones, equipment, and payloads.
About APTO Aptose Biosciences Inc.
Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology. The Company's small molecule cancer therapeutics pipeline includes products designed to provide single agent efficacy and to enhance the efficacy of other anti-cancer therapies and regimens without overlapping toxicities.